-+ 0.00%
-+ 0.00%
-+ 0.00%

Wells Fargo Maintains Overweight on AbbVie, Raises Price Target to $295

Benzinga·07/10/2026 12:26:19
Listen to the news
Wells Fargo analyst Mohit Bansal maintains AbbVie (NYSE:ABBV) with a Overweight and raises the price target from $260 to $295.